Condition: Metastatic Prostate Cancer · Sponsor: University Health Network, Toronto
TOPCOP3 is a pilot factorial RCT of geriatric assessment and management, remote symptom monitoring, both interventions or neither, accompanied by an embedded process evaluation. This design is widely used to guide the evaluation of complex interventions and provides important data to aid design of larger RCTs. The trial itself falls within pilot trial goals including obtaining variance estimates for outcomes, assessment of recruitment potential, and understanding implementation issues vital to designing a larger trial. The investigators have clear feasibility objectives and an analytic plan as well as criteria to determine success and strong support from cancer advocacy and policy groups.
This description comes directly from the study's public registry record.
Shabbir Alibhai, MD · (416) 340-5125 · shabbir.alibhai@uhn.ca
Soha Abdallah, PhD · 416-946-4501 · soha.abdallah@uhn.ca
Always discuss trial participation with your own doctor first.
| St. Michael's hospital | Toronto, Ontario, Canada | Recruiting |
| University Health Network - Princess Margaret Cancer Centre | Toronto, Ontario, Canada | Recruiting |
| Sunnybrook Health Sciences Centre | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05582772